What is Primate Products?
Based in Immokalee, Florida, Primate Products operates as a comprehensive provider of essential equipment and services for the nonhuman primate research community. The company's portfolio is diverse, encompassing specialized handling equipment, sophisticated training apparatus, and enrichment devices designed to improve the quality of life for research subjects. Beyond hardware, the firm provides critical support services, including genetic testing and a dedicated learning center, which serves as a hub for industry best practices.
By integrating a live animal division with its technical product offerings, Primate Products occupies a unique niche in the research supply chain. This vertical integration allows the company to maintain rigorous quality control and provide end-to-end support for laboratories and academic institutions. Their market position is defined by a commitment to ethical research standards and the provision of specialized tools that are indispensable to the advancement of biomedical science.
How much funding has Primate Products raised?
Primate Products has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Primate Products
PPP
Public-Private Partnership
What's next for Primate Products?
With the successful completion of this late-stage financing, Primate Products is well-positioned to accelerate its strategic growth initiatives. The company is expected to focus on enhancing its genetic testing capabilities and expanding its educational outreach through its learning center. Furthermore, the capital will likely be deployed to optimize supply chain logistics and broaden the distribution of its proprietary enrichment devices, which are increasingly recognized as essential components of modern laboratory infrastructure.
As the regulatory landscape for primate research continues to evolve, Primate Products' ability to provide compliant, high-quality solutions will be a key driver of its long-term value proposition. The firm is poised to leverage its current momentum to capture additional market share, potentially exploring new technological integrations that further align its product suite with the shifting requirements of global research partners.
